In an Opinion piece for the Washington Post, Dr. Collins
explains how extraordinary discoveries in biomedical research are within reach
and investing in NIH’s mission is priceless. Washington Post. December
In The Atlantic, Dr. Collins reflects on the funding challenges from 2013 sequester cuts and how a continued lack of investment in biomedical research may curb opportunities for U.S. leadership in the field. The Atlantic. December 18, 2013.
In The Wall Street Journal’s 12 Months of Reading, Dr. Collins recommends that young scientists read Mario Livio's "Brilliant Blunders," which makes a point that scientific blunders can in fact be opportunities rather than setbacks. The Wall Street Journal. December 13, 2013.
The Washington Post Editorial Board explains how funding biomedical research pays a generous return on investment in dollars and in lives saved. Editorial Board. The Washington Post. December 4, 2013.
Dr. Collins and FDA Commissioner Dr. Margaret Hamburg author an article in the Perspective section of the New
England Journal of Medicine, about FDA’s landmark decision to grant marketing authorization for a next-generation sequencer. The article explores how bringing this technology into use for clinical care will transform patient engagement, increase the use of genetic information in health care, and expand research. Collins, Francis S. M.D., Ph.D., and Hamburg, Margaret A., M.D. New England Journal of Medicine. November 19, 2013.
November 8, 2013 — Dr. Collins speaks to Wall Street Journal’s Joseph Rago about the biomedical opportunities at risk from NIH budget cuts. Wall Street Journal.
September 25, 2013 — In a Washington Post article on sequester, Dr. Collins is featured explaining how budget cuts are delaying innovation and costing lives. Washington Post.
September 25, 2013 — Dr. Collins notes that new ideas on cancer, diabetes, autism and heart disease will go unfunded in Thomas Friedman’s New York Times Op-Ed on the state of science in the U.S. New York Times.
September 3, 2013 — Dr. Collins is interviewed by New York Times’ reporter Annie Lowery as part of an article about operating NIH in a time of budget uncertainty. New York Times.
August 23, 2013 — In a one-on-one interview with the Huffington Post, Dr. Collins emphasizes the value of funding scientific research and explains why the sequester impact is worse than predicted. Huffington Post.
August 7, 2013 — In Nature Comment, Dr. Collins and Dr. Kathy Hudson discuss working with the family of Henrietta Lacks on crafting an agreement for access to HeLa genome data. Nature 500, 141–142.
July 25, 2013 — Discover which books can be found on Dr. Collins’ bookshelf and who his favorite childhood authors were, in the NYT’s By the Book. The New York Times.
July 2013 — In the July cover story for Government Executive Magazine, Dr. Collins explains why he isn’t afraid to take risks in his fight for the future of biomedical research. Government Executive Magazine.
May 10, 2013 — NIH Director Dr. Francis Collins, NIMH Director
Dr. Thomas Insel, and NINDS Director Dr. Story Landis author
an article in Science, Vol. 340.
April 23 2013 — Dr. Collins co-authors an article in SciTM explaining the benefits of the PCORI network and how it will help develop clinical research networks with new synergies and efficiencies that partners patients with researchers. Science Translational Medicine Rapid Publication, Vol. 5, Issue 182, p. 182fs13.
January 15, 2013 — Dr. Collins is included in AARP The Magazine’s 50 over 50 ‘Influentials,’ which includes activists and health care professionals that help heal us. AARP The Magazine.
October 1, 2012 — NIH Director Dr. Francis Collins and his research collaborators share what they’ve learned about how basic cell biology can be translated to the clinic. Journal of Cell Biology, Vol. 199.
September 19, 2012 — NIH Director Dr. Francis Collins and NIDDK Director Dr.
Griffin Rodgers address the importance of research in developing practical
and effective strategies to reverse the Nation's obesity epidemic. JAMA.
August 3, 2012 — NIH Director Dr. Francis Collins on NIH's support for basic research.
Read his editorial on the importance of funding basic research and why
it is the engine that powers tomorrow’s therapeutic discoveries. Science,
June 24, 2012 — Mobile devices have the potential to become powerful medical tools
A commentary from NIH Director Francis Collins on mobile health technology and
how it can benefit both patients and researchers. Scientific
American, July 2012 Online Issue.
June 22, 2012 — Policy Forum: Benefits and Risks of Influenza Research: Lessons Learned. Science.
January 2012 — NIH Director Dr. Francis Collins and Dr. Mahendra S. Rao, director for the new NIH Intramural Center for Regenerative Medicine, discuss the role the new center will play for the future of stem cell research. Stem Cells Translational Medicine, Vol. 1.
October 19, 2011 — NIH Director Dr. Collins on innovation in Federal leadership. Washington
Post Federal Coach.
October 14, 2011 — NIH Director Dr. Francis Collins and three fellow NIH experts discuss the effects of household stoves. Read their commentary on one of the leading causes of indoor air pollution that affects nearly half the world's population. Science, Vol. 334.
August 18, 2011 — In a Science commentary, Director Dr. Francis S. Collins and Principal Deputy Director Dr. Lawrence A. Tabak provide a framework for action to address racial differences in NIH grant success rates. Science.
Summer 2011 — Dr. Francis Collins discusses the potential benefit of clinical trials to medical research aimed at improving human health. NIH Medline Plus the Magazine.
In Science Translational Medicine, Director Dr. Francis S. Collins sets forth NIH’s vision for advancing translational sciences. Science Translational Medicine, July 6, 2011.
Dr. Francis Collins discusses the need to apply scientific innovation to global health research. Huffington Post, June 15, 2011
Spring 2011 — The study of the more than 6,000 known rare diseases not only can improve understanding of those disorders, but may also shed new light on hundreds of more common diseases. Dr. Francis Collins discusses the increasing promise of genetics research for the diagnosis, treatment, and prevention of both rare and common diseases. NIH Medline Plus the Magazine.
May–June 2011 — Drawing on NIH research and his own experience, Dr. Francis Collins shares how some relatively simple changes in diet and exercise may lower the risk of developing type 2 diabetes. Arrive.
Spring 2011 — Dr. Francis Collins discusses a variety of topics including whole genome sequencing, NIH’s efforts in global health research, and the Genetic Information Nondiscrimination Act (GINA). Yale Journal of Medicine and Law, Vol. VII, Issue 2.
Winter 2011 — The use of mobile technologies for health research and
healthcare delivery is rapidly expanding. Dr. Francis Collins
discusses the impact of these cell phone technologies on
global health and how NIH is trying to bring medical information
to the public. NIH Medline Plus the Magazine.
February 4, 2011 — To mark the 10th anniversary of the publication of
the draft sequence of the human genome, NIH Director
Francis Collins looks at how systematic genome-wide sequencing
is beginning to be applied to individuals for medical
purposes. Science, Vol. 331.
January 2011 — Dr. Francis Collins, Director of NIH, discusses translational
medicine and NIH efforts to ‘de-risk’ drug
development. Nature Reviews Drug Discovery, Vol.
10, Issue 14.
November 15, 2010 — NIH Director Francis Collins contemplates the future
of the cell biology field and discusses the importance
of collaboration in this rapidly expanding discipline. Molecular
Biology of the Cell, Vol. 21, Issue 22, pp. 3793 – 3794.
October 2010 — NIH Director Francis Collins explains why the NIH is launching
a bid to help some doctoral students dramatically reduce the
time required to start an independent career. Nature, Vol.467, 7.
August 12, 2010 — Nature features Dr. Collins’ achievements
and challenges in his first year as NIH director and highlights
some of his strategies for the future biomedical research. Nature,
Vol. 466, copyright Nature Publishing Group.
July 22, 2010 — Read the article on the future of personalized medicine in the New England Journal
of Medicine by Director Francis S. Collins, M.D., Ph.D. and FDA Commissioner
Margaret A. Hamburg, M.D. (10.1056/NEJMp1006304).
June 23, 2010 — By NIH Director Francis S. Collins, M.D., Ph.D., and AHRQ Director
Carolyn Clancy, M.D, Sci Transl Med.
June 20, 2010 — For an update on the techniques scientists are developing to detect and treat
colorectal cancer, read a Parade article by NIH Director
Francis S. Collins, The Cancer You Can Beat.
June 2, 2010 — Read the commentary in the
Journal of the American Medical Association on comparative effectiveness
research (CER) and NIH’s leadership role by NIH Director Francis
Collins and Dr. Michael Lauer. JAMA. 2010;303(21):2182-2183.
May 24, 2010 — Information about the Notice
of Proposed Rule Making appears in the Journal of the American
Medical Association (JAMA) commentary by NIH Director Francis
Collins and Dr. Sally Rockey. JAMA. 2010;303(23).
May 23, 2010 — For an update
on what medical science is doing to fight the global HIV/AIDS
pandemic, read a Parade article by NIH Director Francis
S. Collins and NIAID Director Anthony S. Fauci, AIDS
in 2010: How We're Living with HIV.
May 22, 2010 — Remarkable advances have been made in understanding the human genome's contribution
to health and disease since the first Genomic Medicine series
April 1, 2010 — Looking back over the past decade of human genomics, Francis Collins
finds five key lessons for the future of personalized medicine — for
technology, policy, partnerships and pharmacogenomics. Nature 464,
February 21, 2010 — For a look
at how imaging technologies are helping to transform medicine,
read a Parade article by NIH Director Francis S. Collins, Revealing
the Body’s Deepest Secrets.
January 1, 2010 — The mission of the National Institutes of Health (NIH) is science in pursuit
of fundamental knowledge about the nature and behavior of living
systems and the application of that knowledge to extend healthy
life and to reduce illness and disability.
This page last reviewed on
July 24, 2014